The discovery of an expanded (CTG).
repeat sequence in myotonic dystrophy (DM) has greatly improved our ability to detect DM gene carriers who have few or none of the classical signs of this disorder. We report here our experience with two such groups of gene carriers. We used a PCR based protocol that should be especially sensitive to small increases in CTG triplet number which might escape detection by conventional Southern blot analysis. Our analyses show that on 100 non-DM chromosomes the number of CTG triplets ranged from five to 37. We then studied 17 obligate gene carriers aged 55 years and over who showed no muscle weakness. All of the gene carriers in this group showed a relatively small increase in the number of CTG triplets (52 to 90 CTG triplets) with limited somatic mosaicism. We subsequently studied 11 subjects (aged 19 to 36 years) who had previously been identified as gene carriers by genetic linkage studies, but who lacked diagnostic signs. In this prospectively studied group, nine subjects showed an expanded allele, confirming the earlier prediction from linked genetic markers. The other two subjects had only two normal alleles and no expanded allele. Revision of the clinical data casts doubt on the original diagnosis of DM in their families. Preferential amplification of the normal non-expanded allele was noted in three asymptomatic gene carriers in this study ( There is a marked tendency for an increase in CTG triplet number from one generation to the next, which is paralleled by earlier onset of the disease in successive generations,"1 12 a phenomenon known as anticipation. Genealogical studies in DM families'"'5 suggest that in earlier generations additional asymptomatic gene carriers may have been present, presumably with only a minor expansion of the CTG motif. However, a premutation not involving expansion of the CTG trinucleotide repeat is another possibility. This situation is highly reminiscent of the CCG repeat expansion seen in the fragile X syndrome. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Our previous study using linked DNA markers has suggested that a considerable proportion of sibs and offspring of DM patients are asymptomatic in early adulthood.'9 Therefore, asymptomatic subjects may not be confined to the early generations of a DM family.
We studied these issues in detail by assaying the CTG triplet number in 17 15, and 17,  fig 2) . The 1% agarose Southern blot of the PCR product shows the expected band of approximately 0-2 kb for these subjects. Above this band, a smear can be detected, which is frequently observed for alleles of this size, and which may be the result of heteroduplex formation of normal and expanded alleles, rather than somatic mosaicism. Symptomatic disease has been diagnosed in the descendants of these obligate carriers (111.1, 2, 3, fig 3) . These ... We currently estimate the chance that a clinically normal sib or offspring of a DM patient carries a mutated gene to be 7-8% for those aged between 20 and 39 years of age. This figure is very similar to our previous estimate in the same sample of DM families (8 3%). 19 We have now excluded two subjects because of unreliable diagnosis, while we had formerly anticipated the reclassification as low risk of two subjects because of genetic recombination with the marker loci. '9 In addition, our study confirms that at the molecular level anticipation is the rule in DM, since in our sample of nine asymptomatic offspring we always found a CTG triplet number equal to or exceeding that of the affected parent. Finally, we do not know the explanation for the family in which expansion of the CTG repeat was not detected in either clinically affected member. Such families have been noted by others.7 It remains to be seen whether the results in these families are the result of diagnostic error or allelic mutation. The existence of allelic mutations, not causing expansion of the CCG repeat sequence, has been suggested for the fragile X syndrome. 3 Finally, we want to stress that in subjects with only a single normal band by PCR, the DM mutation should not be considered excluded, because of the possibility of preferential amplification of the normal allele. In such instances, additional studies are required, using either alternative primer combinations, conventional Southern blotting of genomic fragments, or linked genetic markers. Only when such studies confirm the presence of normal alleles only, can the consultand be reassured that future offspring will not be at risk.
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